Amylyx Pharmaceuticals (AMLX) Change in Cash (2021 - 2026)

Amylyx Pharmaceuticals' Change in Cash history runs 6 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 114.11% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $168.9 million (up 253.47% YoY), while the FY2025 annual figure was $148.8 million, up 261.59% from the prior year.
• Change in Cash was $2.5 million for Q1 2026 at Amylyx Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $166.6 million in Q3 2025 to a low of -$112.5 million in Q3 2023.
• Historically, Change in Cash has averaged $10.6 million across 5 years, with a median of $1.5 million in 2025.
• Biggest YoY gain for Change in Cash was 6934.5% in 2025; the steepest drop was 5121.08% in 2025.
• A 5-year view of Change in Cash shows it stood at -$45.2 million in 2022, then jumped by 177.29% to $34.9 million in 2023, then sank by 84.1% to $5.6 million in 2024, then plunged by 73.46% to $1.5 million in 2025, then surged by 68.54% to $2.5 million in 2026.
• The last three Change in Cash figures came in at $2.5 million (Q1 2026), $1.5 million (Q4 2025), and $166.6 million (Q3 2025), per Business Quant data.